Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders
Abstract
An anti-tau monoclonal antibody tau-2 was demonstrated to react with the cells which characteristically appeared in the subcortical nuclei of certain neurodegenerative disorders. These cells had rod-like cell bodies and elongated processes, whose morphology was consistent with that of reactive microglia (tau-2 positive microglia-like cells; TPMC). TPMC were diffusely scattered in the subcortical nuclei, especially the putamen, irrelevant to focal tissue injury such as infarcts and amyloid deposits. TPMC were positively immunostained with anti-ferritin antibody, but negatively with LN3, anti-GFAP, other kinds of anti-tau and anti-neurofilament antibodies. TPMC were found in some cases of Alzheimer type dementia and diffuse Lewy body disease, but not in the cases of Parkinson's disease, Pick's disease and control without neurological disorder. Similar microglia-like cells were found around infarctic foci and amyloid cores of senile plaques, regardless of the disorder. They were, however, different from TPMC in that they were positively immunostained with LN3.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tau inclusions have been reported in microglia despite a lack of tau expression, providing evidence that pathological tau may transfer between cells in the brain.
“Tau inclusions have also been reported in microglia [80–82] despite a lack of tau expression, providing further evidence that pathological tau may also be transferring between cells in the brain.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [80]
The citation lists haven’t been fetched yet
References 5 · Cited by 47
- Authors
- Odawara, T., Iseki, E., Kosaka, K., Akiyama, H., Ikeda, K., & Yamamoto, T.
- Affiliations
- Yokohama City University (JP)
- Tokyo Institute of Psychiatry (JP)
- Fukushimura Hospital (JP)
- Corresponding author
- Iseki, Eizo
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 192
- Issue
- 3
- Pages
- 145-148
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2055391668
- Cited by
- 47
- References
- 5
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- reactive microglia, subcortical nuclei, neurodegenerative diseases, Alzheimer-type dementia, dementia with Lewy bodies, Parkinson's disease, Pick's disease, putamen, amyloid plaques, amyloid core, infarction, ferritin, glial fibrillary acidic protein, neurofilaments
- MeSH terms
- Aged, Aged, 80 and over, Brain Chemistry, Cerebral Cortex, Female, Hippocampus, Humans, Immunohistochemistry, Male, Middle Aged, Nerve Degeneration, Nervous System Diseases, tau Proteins, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review